How adverse drug reactions can play a role in innovative drug research
- 1 November 1995
- journal article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 17 (6) , 195-200
- https://doi.org/10.1007/bf01870611
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Angiotensin converting enzyme inhibitors. An overview.Hypertension, 1991
- History of the design of captopril and related inhibitors of angiotensin converting enzyme.Hypertension, 1991
- Effects of prolonged administration of d-penicillamine or captopril in various strains of ratsClinical Immunology and Immunopathology, 1984
- Angiotensin converting enzyme inhibitorsInternational Journal of Clinical Pharmacy, 1982
- Historical perspectives on the renin-angiotensin-aldosterone system and angiotensin blockadeThe American Journal of Cardiology, 1982
- Angiotensin-converting enzyme inhibition: A developing therapeutic concept: Introduction to session I: DevelopmentThe American Journal of Cardiology, 1982
- Thou, gentle viper: An introductionThe American Journal of Cardiology, 1982
- Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseasesSpringer Seminars in Immunopathology, 1981
- CaptoprilDrugs, 1980
- CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILUREThe Lancet, 1979